Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuPath HealthTSXV:NPTH 39 Gross Margin % is 18.99% as of Jun. 2026, which is 0% below its 10-year median of 19.03. GuruFocus rates TSXV:NPTH with a GF Score™ of 39/100 and a GF Value™ of C$0.25 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 635 Healthcare Providers & Services companies, NeuPath Health ranks worse than 86.46% on this metric.
The historical rank and industry rank for NeuPath Health's Gross Margin % or its related term are showing as below:
TSXV:NPTH'
s Gross Margin % Range Over the Past 10 Years
Min: 17.27 Med: 19.03 Max: 20.4
Current: 18.71
During the past 7 years, the highestGross Margin % of NeuPath Health was 20.40%. The lowest was 17.27%. And the median was 19.03%.
TSXV:NPTH's Gross Margin % is ranked worse than 86.46% of 635
companies
in the Healthcare Providers & Services industry
Industry Median: 40.23
vs TSXV:NPTH: 18.71
NeuPath Health had a gross margin of 18.99% for the quarter that ended in Jun. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for NeuPath Health was -0.40% per year.
NeuPath Health (TSXV:NPTH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
NeuPath Health had a gross margin of 18.99% for the quarter that ended in Jun. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
NeuPath Health Gross Margin % Related Terms
NeuPath Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for NeuPath Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:NPTH vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, NeuPath Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuPath Health Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where NeuPath Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
NeuPath Health (TSXV:NPTH) has a Gross Margin % of 18.99% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on NeuPath Health and its competitors. This is near median its historical median of 19.03. Over the past decade, NeuPath Health's Gross Margin % has ranged from 17.27 to 20.40. According to the industry distribution chart, NeuPath Health ranks #549 out of 635 companies in the Healthcare Providers & Services industry, placing it in the top 86.5%.
Is NeuPath Health's Gross Margin % too high?
NeuPath Health's current Gross Margin % of 18.99% is near median its 10-year median of 19.03. Over the past 10 years, this metric has ranged from a low of 17.27 to a high of 20.40. The Healthcare Providers & Services industry median Gross Margin % is 40.23. NeuPath Health's value of 18.99% is 52.8% below this industry median. Based on the distribution chart, NeuPath Health ranks #549 out of 635 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NeuPath Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NeuPath Health's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, NeuPath Health ranks #549 out of 635 companies for Gross Margin %. This places NeuPath Health in the lower half of its industry. The industry median Gross Margin % is 40.23. NeuPath Health's value of 18.99% is 52.8% below this benchmark. Historically, NeuPath Health's own Gross Margin % has ranged from 17.27 to 20.40 over the past decade. While the company's 10-year median is 19.03 vs. the industry median of 40.23, NeuPath Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuPath Health's current Gross Margin % of 18.99% is 52.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on NeuPath Health and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuPath Health's current Gross Margin % is 18.99%, which is near median its own 10-year median of 19.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuPath Health stock overvalued right now?
Based on GuruFocus' analysis, NeuPath Health (TSXV:NPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.25, compared to a current price of C$0.55 — trading 120% above its estimated fair value. The current Gross Margin % is 18.99%, which is near median its 10-year median of 19.03 and 52.8% below the Healthcare Providers & Services industry median of 40.23. NeuPath Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For NeuPath Health (TSXV:NPTH), the current Gross Margin % is 18.99% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuPath Health (TSXV:NPTH) Overvalued in 2026?
Based on GuruFocus' analysis, NeuPath Health stock appears to be overvalued.
The current stock price of C$0.55 is trading 120% above its estimated GF Value™ of C$0.25.
GuruFocus considers NeuPath Health to be Significantly Overvalued.
Key valuation signals for TSXV:NPTH:
Gross Margin %: 18.99% (near median its 10-year median of 19.03)
GF Value™: C$0.25 vs. price of C$0.55 (120% above fair value)
Industry Position: 52.8% below the Healthcare Providers & Services median (#549 of 635)
No single metric tells the full story. See the TSXV:NPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions. The company operates in one industry segment: medical services.
39GF Score
Get the complete analysis for TSXV:NPTH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NPTH has been successfully added to your 
